Clinical Trials Logo

Clinical Trial Summary

This is a randomized, double-blind, crossover study in healthy adult subjects. Each subject will receive a single dose of bisoprolol 5 mg p.o. and nebivolol 5 mg p.o. with 1 week washout period. All subjects will undergo a physical examination, 12-lead electrocardiography and a comprehensive echocardiographic study before the administration of the study drug and 5 hours thereafter.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04432610
Study type Interventional
Source Clinical Hospital Center Zemun
Contact
Status Withdrawn
Phase Phase 4
Start date January 2030
Completion date December 2030